Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”

키워드

참고문헌 (10)

1. Yang JD, "A global view of hepatocellular carcinoma : trends, risk, prevention and management", Nat Rev Gastroenterol Hepatol, 16, pp.589~604 (2019)
2. Parikh ND, "Blood-based biomarkers for hepatocellular carcinoma screening : Approaching the end of the ultrasound era?", J Hepatol, 78, pp.207~216 (2023)
3. Hong J, "Multiomics profiling of buffy coat and plasma unveils etiologyspecific signatures in hepatocellular carcinoma", Clin Mol Hepatol, 30, pp.360~374 (2024)
4. Levrero M, "Mechanisms of HBV-induced hepatocellular carcinoma", J Hepatol, 64(1 Suppl), pp.S84~S101 (2016)
5. Wegermann K, "Molecular mechanisms linking nonalcoholic steatohepatitis to cancer", Clin Liver Dis(Hoboken), 17, pp.6~10 (2021)
6. Singal AG, "Epidemiology and surveillance for hepatocellular carcinoma : New trends", J Hepatol, 72, pp.250~261 (2020)
7. Bruix J, "Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma", Gastroenterology, 150, pp.835~853 (2016)
8. Forner A, "Hepatocellular carcinoma", Lancet, 391, pp.1301~1314 (2018)
9. Lehrich BM, "Battle of the biopsies : Role of tissue and liquid biopsy in hepatocellular carcinoma", J Hepatol, 80, pp.515~530 (2024)
10. Sia D, "Liver cancer cell of origin, molecular class, and effects on patient prognosis", Gastroenterology, 152, pp.745~761 (2017)

관련 논문AI추천